How have MEDS shares performed in 2024?

TRxADE HEALTH's stock was trading at $5.20 at the beginning of 2024. Since then, MEDS shares have increased by 31.7% and is now trading at $6.85. View the best growth stocks for 2024 here .

Are investors shorting TRxADE HEALTH?

TRxADE HEALTH saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 34,000 shares, a drop of 39.3% from the March 15th total of 56,000 shares. Based on an average trading volume of 417,300 shares, the short-interest ratio is presently 0.1 days. Approximately 4.0% of the company's stock are sold short. View TRxADE HEALTH's Short Interest .

When is TRxADE HEALTH's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our MEDS earnings forecast .

How were TRxADE HEALTH's earnings last quarter?

TRxADE HEALTH, Inc. (NASDAQ:MEDS) issued its quarterly earnings data on Sunday, October, 24th. The company reported ($2.40) EPS for the quarter, missing analysts' consensus estimates of ($1.95) by $0.45. The firm earned $2.55 million during the quarter, compared to analysts' expectations of $1.94 million. TRxADE HEALTH had a negative trailing twelve-month return on equity of 69.22% and a negative net margin of 78.18%. During the same period in the previous year, the company earned $0.30 EPS.

How often does TRxADE HEALTH pay dividends? What is the dividend yield for TRxADE HEALTH?

TRxADE HEALTH announced a dividend on Wednesday, February 28th. Investors of record on Monday, March 18th will be paid a dividend of $8.00 per share on Friday, March 22nd. The ex-dividend date of this dividend is Monday, March 25th. Read our dividend analysis for MEDS .

When did TRxADE HEALTH's stock split?

Shares of TRxADE HEALTH reverse split before market open on Thursday, June 22nd 2023. The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of TRxADE HEALTH own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TRxADE HEALTH investors own include Advanced Micro Devices (AMD) , Biocept (BIOC) , iBio (IBIO) , Ollie's Bargain Outlet (OLLI) , OPKO Health (OPK) , Alto Ingredients (PEIX) , Tiziana Life Sciences (TLSA) and Trevena (TRVN) .

How do I buy shares of TRxADE HEALTH?

Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:MEDS

TRxADE HEALTH (MEDS) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free MEDS Stock Alerts

$6.66

-0.27 (-3.90%)

(As of 12:58 PM ET)

Compare

Today's Range: $6.47
▼
$7.25
50-Day Range: $4.11
▼
$33.90
52-Week Range: $3.69
▼
$44.56

Volume: 57,211 shs
Average Volume: 361,755 shs
Market Capitalization: $8.06 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get TRxADE HEALTH alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About TRxADE HEALTH Stock (NASDAQ:MEDS)

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.

MEDS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MEDS Stock News Headlines

April 18, 2024 | msn.com

Lexington among cities with highest cost of prescription medications, study shows

April 17, 2024 | msn.com

What Medications Can Cause Antiphospholipid Syndrome? A Review By Doctors

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 17, 2024 | msn.com

On Your Side: Know this about flea and tick medications

April 16, 2024 | americanbankingnews.com

TRxADE HEALTH (NASDAQ:MEDS) Shares Down 0.1%

April 11, 2024 | msn.com

This multifunctional system can send drugs where they can be effective in body’s tissues, organs

April 11, 2024 | msn.com

Hundreds of drugs are in short supply around the U.S., pharmacists warn

April 1, 2024 | msn.com

ZenCortex Review: 180 Days Evaluation – Does This Ear Health Supplement Really Work?

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 31, 2024 | msn.com

These Common Medications Could Have Terrifying Side Effects

March 29, 2024 | msn.com

Medicare increase in spending on diabetes drugs could cost seniors more money

March 29, 2024 | msn.com

March 12, 2024 | msn.com

FAIR Meds Act could impact costs for prescriptions

March 12, 2024 | msn.com

A massive cyberattack has some Arizona health providers reeling. Here's what we know

March 11, 2024 | msn.com

Texas health centers awarded over $19 million in grants

March 11, 2024 | msn.com

Lexicon Pharmaceuticals, Mesoblast, Ventyx Biosciences among healthcare movers

March 6, 2024 | msn.com

Crude Oil Rises Sharply; Foot Locker Shares Plunge

March 6, 2024 | msn.com

TRxADE Health Stock Skyrockets: Here's Why

March 6, 2024 | globenewswire.com

TRxADE Health, Inc. Announces Special Cash Dividend

February 20, 2024 | msn.com

New model identifies drugs that shouldn’t be taken together

February 20, 2024 | seekingalpha.com

GCT, VHC and IPWR among mid-day movers

February 20, 2024 | msn.com

TRxADE HEALTH Rises Over 140% - What's Going On?

February 20, 2024 | msn.com

Why Is Trxade Health (MEDS) Stock Up 230% Today?

February 20, 2024 | investorplace.com

Why Is Trxade Health (MEDS) Stock Up 230% Today?

February 19, 2024 | msn.com

There are spurious drugs for cancer, hypertension, cholesterol, pediatric diseases…only lab tests can spot them’

February 6, 2024 | msn.com

Is this a scam? Prescription drugs cost 3 times more in the U.S. than in other wealthy countries

February 2, 2024 | msn.com

Fractyl Health valued at $654.6 mln in tepid debut

See More Headlines

Receive MEDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/24/2021
Dividend Payable: 3/22/2024
Ex-Dividend for 3/22 Dividend: 3/25/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Drugs, proprietaries, & sundries
Sub-Industry: N/A
Current Symbol: NASDAQ:MEDS
CUSIP: N/A
CIK: 1382574
Web: www.trxade.com
Phone: (800) 261-0281
Fax: 800-265-6932
Employees: 33
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($6.9388)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-3,470,000.00
Net Margins: -78.18%
Pretax Margin: -43.63%
Return on Equity: -69.22%
Return on Assets: -23.52%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.61
Quick Ratio: 0.28

Sales & Book Value

Annual Sales: $11.45 million
Price / Sales: 0.73
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.55 per share
Price / Book: 12.60

Miscellaneous

Outstanding Shares: 1,210,000
Free Float: 622,000
Market Cap: $8.39 million
Optionable: Not Optionable
Beta: 2.01

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Surendra K. Ajjarapu (Age 53)
Founder, Chairman, CEO & Secretary
Comp: $354.23k
Mr. Prashant Patel R.Ph. (Age 50)
Founder, President, COO, Interim CFO, Interim Principal Financial & Accounting Officer and Director
Comp: $147.04k
Dr. Ramesh Kenchappa
Chief Scientific Officer
Mr. David M. Saslow Esq.
Inhouse Counsel
Mr. Jariel Morales
Executive Vice President
Dr. Shafaat Pirani Pharm.D.
Executive Vice President of Alliance Pharma Solutions, LLC

Key Competitors

View All Competitors

MEDS Stock Analysis - Frequently Asked Questions

How have MEDS shares performed in 2024?: TRxADE HEALTH's stock was trading at $5.20 at the beginning of 2024. Since then, MEDS shares have increased by 31.7% and is now trading at $6.85.
View the best growth stocks for 2024 here.
Are investors shorting TRxADE HEALTH?: TRxADE HEALTH saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 34,000 shares, a drop of 39.3% from the March 15th total of 56,000 shares. Based on an average trading volume of 417,300 shares, the short-interest ratio is presently 0.1 days. Approximately 4.0% of the company's stock are sold short.
View TRxADE HEALTH's Short Interest.
When is TRxADE HEALTH's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our MEDS earnings forecast.
How were TRxADE HEALTH's earnings last quarter?: TRxADE HEALTH, Inc. (NASDAQ:MEDS) issued its quarterly earnings data on Sunday, October, 24th. The company reported ($2.40) EPS for the quarter, missing analysts' consensus estimates of ($1.95) by $0.45. The firm earned $2.55 million during the quarter, compared to analysts' expectations of $1.94 million. TRxADE HEALTH had a negative trailing twelve-month return on equity of 69.22% and a negative net margin of 78.18%. During the same period in the previous year, the company earned $0.30 EPS.

How often does TRxADE HEALTH pay dividends? What is the dividend yield for TRxADE HEALTH?: TRxADE HEALTH announced a dividend on Wednesday, February 28th. Investors of record on Monday, March 18th will be paid a dividend of $8.00 per share on Friday, March 22nd. The ex-dividend date of this dividend is Monday, March 25th.
Read our dividend analysis for MEDS.
When did TRxADE HEALTH's stock split?: Shares of TRxADE HEALTH reverse split before market open on Thursday, June 22nd 2023. The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.
What other stocks do shareholders of TRxADE HEALTH own?: Based on aggregate information from My MarketBeat watchlists, some companies that other TRxADE HEALTH investors own include Advanced Micro Devices (AMD), Biocept (BIOC), iBio (IBIO), Ollie's Bargain Outlet (OLLI), OPKO Health (OPK), Alto Ingredients (PEIX), Tiziana Life Sciences (TLSA) and Trevena (TRVN).
How do I buy shares of TRxADE HEALTH?: Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MEDS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

TRxADE HEALTH (MEDS) Stock Price, News & Analysis

About TRxADE HEALTH Stock (NASDAQ:MEDS)

MEDS Stock Price History

MEDS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

MEDS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info